SUMMARY The activity of tetracycline hydrochloride and minocycline hydrochloride was compared against 12 strains of Chlamydia trachomatis and Ureaplasma urealyticum; minocycline was more active in vitro against both organisms. A group of 145 men with non-gonococcal urethritis was treated for one week with either tetracycline hydrochloride 500 mg six hourly or minocycline 50 mg twice daily. The clinical results obtained were similar: 61 of 77 (79%) men treated with tetracycline and 53 of 68 (78%o) men treated with minocycline were free from urethritis one to two weeks after completing treatment. Both antibiotics were clinically effective against C trachomatis, but activity against U urealyticum was less consistent. Side effects were noted in 14 (18%7o) men treated with tetracycline and eight (12%) men treated with minocycline; they were predominantly gastrointestinal.
Introduction
Chlamydia trachomatis is a major cause of nongonococcal urethritis (NGU),I and although the role of Ureaplasma urealyticum is less clear it is believed to cause some cases.2 Between 25% and 50% of cases of NGU are of unknown aetiology. The tetracyclines are in general use for the treatment of NGU. C trachomatis is consistently sensitive,3 but between 6% and 10% of strains of U urealyticum are resistant, and these may cause some treatment failures. 4 The choice of tetracycline for bacterial treatment is not unimportant; for example, tetracycline-resistant strains of Haemophilus influenzae are inhibited by minocycline,5 and anaerobic bacteria are more responsive to minocycline than to tetracycline or doxycycline. 6 The action of tetracyclines against C trachomatis may be studied in cell culture. If tetracyclines are added one hour after C trachomatis there is little difference between the effect of tetracycline, minocycline, or doxycycline, but if they are added 48 hours after inoculation minocycline and doxycycline are much more active than tetracycline.3 The results of the action of tetracycline against U urealyticum in vitro are conflicting and seem to depend on the laboratory procedure used,78 but tetracycline-resistant strains also appear to be resistant to minocycline.9
In this study we first compared the activity of tetracycline and minocycline against 12 fresh isolates of C trachomatis and U urealyticum and then treated a group of men with NGU with either antibiotic for one week and compared the clinical and microbiological results.
Patients and methods
The isolates of C trachomatis and U urealyticum for determination of minimum inhibitory concentrations (MICs) were obtained from unselected men with NGU. The clinical study was 
SIDE EFFECTS
Of the 77 men treated with tetracycline, 14 (18%) reported side effects: drowsiness (4) , nausea (5), epigastric pain (4) , and sore tongue (1) . Of the 68 treated with minocycline, eight (120/) reported side effects: drowsiness (1), epigastric pain (2) , bad taste in mouth (1) , flatulence (1) , dizziness of less than one day's duration (2) , and a fixed drug eruption (1) .
RESULTS OF TETRACYCLINE TREATMENT
Tetracycline was given to 77 men with NGU; before treatment C trachomatis was isolated from 31 (400o) and Uurealyticum from 28 (360/) of these men (table  II) . When re-examined one to two weeks after the end of treatment 61 (790/) of the 77 men were free of urethritis (table III) . This result was not affected by the presence or absence of C trachomatis or U urealyticum before treatment. Thus, of the 31 men who were initially chlamydia-positive and of the 46 who were initially chlamydia-negative, 26 (840/) and 35 (760o) respectively had no urethritis after treatment. These differences were not significant (x2 = 0-291, p>05). Of 28 men initially ureaplasmapositive and of 49 initially ureaplasma-negative, 21 (750/) and 39 (800/) respectively showed no urethritis after treatment. These differences were not significant (x2 = 0-076, p>0 5). Isolates of C trachomatis had been obtained from 31 of 77 men with NGU before treatment, but the organisms were not recovered from any of these patients one to two weeks after treatment. Isolates of U urealyticum were obtained from 28 of the 77 men before treatment. It was reisolated from four (14%) of these 28 men one to two weeks after treatment and isolated for the first time from a further two men. Of the six men yielding ureaplasmas after treatment, three had persistent urethritis and three no disease.
Re-examination at or after three weeks after treatment of 48 men who had shown no urethritis one to two weeks after treatment indicated that nine (190o) then had evidence of urethritis; all admitted to further sexual intercourse. C trachomatis was not recovered from any of the 48 men. U urealyticum was recovered from one man (previously culturenegative) without urethritis. It was not isolated from any of the nine men with urethritis, and the aetiology of their disease could not be determined.
RESULTS OF MINOCYCLINE TREATMENT
Minocycline was given to 68 men with NGU; before treatment C trachomatis was isolated from 24 (35%) and U urealyticum from 32 (47%) of these men (table   II) . When re-examined one to two weeks after the end of treatment, 53 (78%) of the 68 men were free of urethritis. This result was not affected by the presence or absence of C trachomatis or U urealyticum before treatment. Thus, of the 24 men who were initially chlamydia-positive and of the 44 who were initially chlamydia-negative, 22 (920/o) and 32 (73%) respectively had no urethritis after treatment. These differences were not significant (x2 = 2-5, 0-5>p>0 1). Of 32 men initially ureaplasmapositive and of 36 initially ureaplasma-negative, 23 (72%) and 30 (83%) respectively showed no urethritis after treatment. These differences were not significant (x2 = 0 713, p>0 5).
Isolates of C trachomatis had been obtained from 24 of 68 men with NGU before treatment, but the organisms were not recovered from any of these men one to two weeks after treatment. Isolates of U urealyticum were obtained from 32 of the 68 men before treatment. It was reisolated from four of these 32 (12-5%) men one to two weeks after treatment; one showed persistent urethritis but the other three no disease.
In 40 men who had had no urethritis one to two weeks after treatment, re-examination at or after three weeks after treatment indicated that four (10/o) then showed evidence of urethritis; three admitted to further sexual intercourse. C trachomatis was not recovered from any of these 40 men. U urealyticum was recovered from two of the four men with urethritis (both previously culture-negative) but from none of the 36 without urethritis.
Discussion
The in vitro results (table I) confirm previous reports of the activity of tetracycline and minocycline against C trachomatis and U urealyticum.37 The results of the clinical studies were in general consistent with this, but C trachomatis responded more uniformly than U urealyticum. All the men with chlamydiapositive NGU were culture-negative after treatment with either drug and remained so during surveillance for up to six weeks from the completion of treatment. In contrast, U urealyticum was reisolated one to two weeks after treatment from five of 28 men with ureaplasma-positive NGU who were treated with tetracycline and four of 32 men treated with minocycline. Reinfection after early resumption of sexual intercourse is possible (see 
